Top Markets
#1 Black Phoenix Black Phoenix +736.70%
#2 Beam Beam +35.79%
#3 SAFEcoin SAFEcoin +19.80%
#4 TENDIES TENDIES +17.80%
#5 THORChain THORChain +17.71%
#6 Tutorial Tutorial +16.47%
#7 EfficientFrontier EfficientFrontier +15.89%
#8 Bless Bless +14.32%
#9 THORChain Yield THORChain Yield +13.26%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
Clasificación en acciones #5675
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
Precio por acción
$62.49
Última sincronización: 2024-03-06
Capitalización bursátil
$2.52B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio RayzeBio, Inc. Common Stock (RYZB)

Categoría

Healthcare
EPS de RayzeBio, Inc. Common Stock (RYZB)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de RayzeBio, Inc. Common Stock, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de RayzeBio, Inc. Common Stock desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH